ESMO WORLD CONGRESS ON GASTROINTESTINAL CANCER

ESMO World Congress on Gastrointestinal Cancer

 

30 June -3 July 2021 Virtual Conference
Close
N. Poster
Poster title
Applicant name
Status
  PD-1 MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress) Natalie Pizzimenti Received Received
  P-1 Health-related quality of life of rectal cancer survivors treated with curative intent André Ferreira Received Received
  PD-3 Impact of RAS status, prior targeted therapy, age, and gender on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer: Real-world data from the QoLiTrap study Roger von Moos Received Received
  P-3 Gastric cancer: 10-year survival Oleg Kshivets Received Received
  P-4 Prognostic and therapeutic values of tumor-infiltrating lymphocytes in localized colon cancer sonia Ben Nasr Received Received
  P-5 The use of complementary and alternative medicine among colorectal cancer patients in Tunisia sonia Ben Nasr Received Received
  SO-7 The prognostic and predictive role of preoperative chemotherapy sensitivity in gastric adenocarcinoma: A study of national cancer database Lei Deng Received Received
  P-7 How much can GIT cancer patients afford for effective and safe treatment? Rasha Aboelhassan Received Received
  P-8 Nutritional status among colorectal cancer patients in Tunisia sonia Ben Nasr Received Received
  P-9 Prognostic role of preoperative inflammation parameters in predicting postoperative complications of colorectal cancer surgery. sonia Ben Nasr Received Received
  P-10 Prevalence and risk factors of chronic neuropathy in 225 colorectal cancer patients treated with oxaliplatin-based regimens in Tunisia sonia Ben Nasr Received Received
  P-11 GAME score in patients with liver metastases from colorectal cancer Wala Ben Kridis Received Received
  O-11 Monitoring molecular residual disease by circulating tumor DNA in resectable colorectal cancer: Molecular subgroup analyses of a prospective observational study GALAXY in CIRCULATE-Japan Hiromichi Shirasu Received Received
  P-12 Long intergenic non-protein coding RNA 1094 regulates the progression of gastric cancer Ouyang Ge Received Received
  O-13 Gut microbiome to predict survival time in advanced gastric cancer treated with nivolumab: The DELIVER trial (JACCRO GC-08) Yu Sunakawa Received Received
  P-14 The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with pancreatic cancer bengueddach aicha Received Received
  SO-15 Quality of life and physical functioning in older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study Gabor Liposits Received Received
  P-15 Diagnostic potential of erythrocyte and serum fatty acids in spotting adenomatous polyps and identifying the early stages of colorectal cancer depending on tumor localization Margarita Kruchinina Received Received
  P-16 How does reinduction of first-line chemotherapy in patients with metastatic colorectal cancer impact outcomes? Experience from the University Hospital for Tumors, Zagreb, Croatia Mirjana Pavlovic Received Received
  SO-16 Quality of life in Finnish metastatic colorectal cancer patients actively treated with the aim of maximizing resection and/or local ablative therapy (RAXO-study NCT01531595) Pia Osterlund Received Received
  P-17 CT colonography: A minimally invasive screening option for colorectal cancer Jagmeet Grewal Received Received
  P-19 Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres followed by Gemcitabine plus Cisplatin for Treatment of Intra-hepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial Stephen Lam Chan Received Received
  P-20 Concurrent chemo-radiotherapy in anal squamous cell carcinomas: A 10-year retrospective review of a tertiary centre experience Abdelfattah Elmasry Received Received
  SO-20 Prospective validation of Ang-2 and Tie-2 plasma levels as predictors of benefit from regorafenib in metastatic colorectal cancer patients: REGOLAND study. Carlotta Antoniotti Received Received
  SO-21 Impact of timing of perioperative chemotherapy on survival outcomes among patients with colorectal liver metastases: A propensity score matching of the national cancer database Firas Baidoun Received Received
  P-22 Role of timing to laparoscopic or robotic surgery after neoadjuvant chemoradiotherapy for rectal cancer: The TiMiSNAR trial Igor Monsellato Received Received
  SO-24 Circulating tumor DNA variant allelic fraction as a surrogate for disease burden estimation in patients with RAS wild-type metastatic colorectal cancer: A secondary endpoint of the VALENTINO study Paolo Manca Received Received
  P-25 A review of circulating exosomal biomarkers in the diagnosis of pancreatic cancer Menazir Sha Received Received
  SO-25 Global rise in early-onset colorectal cancer: An association with antibiotic consumption? Sarah Perrott Received Received
  P-27 The efficacy and safety of XELOX/SOX plus bevacizumab as neoadjuvant chemotherapy for locally advanced rectal cancer compared with XELOX/SOX: A retrospective study Nanako Sakaguchi Received Received
  P-31 Real-world efficacy and safety of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies Nieves Martinez Lago Received Received
  P-32 SARS-CoV-2 pandemic and delayed presentation of gastrointestinal cancer patients: A retrospective evaluation and the impact on clinical outcome Budhi Ida Bagus Received Received
  P-33 Results of initial DPYD screening for cancer patients receiving fluoropyrimidines Matilde Bolaños Received Received
  P-34 Real-world efficacy and safety of immune checkpoint inhibitors in microsatellite unstable or mismatch repair deficient gastrointestinal tumors Nieves Martinez Lago Received Received
  P-37 SGNTUC-019: Phase 2 basket study of tucatinib and trastuzumab in previously treated solid tumors with HER2 alterations: Biliary tract cancer cohort (trial in progress) Tanios Bekaii-Saab Received Received
  P-38 Unmet needs and concerns of Russian patients with CRC: Analysis of Russian internet postings Aleksandr Krotkevich Received Received
  P-42 Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies as treatment option in vulnerable older patients with metastatic colorectal cancer: A retrospective cohort study Gerardo Rosati Received Received
  P-43 C677T and A1298C MTHFR gene polymorphisms and response to fluoropyrimidine-based chemotherapy in mestizo patients with metastatic colorectal cancer. Allan Ramos-Esquivel Received Received
  P-47 5-fluorouracil bolus use in infusional regimens among oncologists: A survey by Brazilian Group of Gastrointestinal Tumors RENATA PEIXOTO Received Received
  P-52 Overall survival with cetuximab every 2 weeks vs standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumor location Stefan Kasper Received Received
  P-54 Higher muscle mass is associated with better response to concurrent neoadjuvant chemoradiotherapy in rectal cancer patients Kiril Zhelev Received Received
  P-63 MATTERHORN: Efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer - randomised, double-blind, placebo-controlled, Phase 3 study Yelena Yuriy Janjigian Received Received
  P-64 The?impact of?sarcopenia?on overall survival?among?cholangiocarcinoma patients: A systematic review?and meta-analysis Jeannette Tandiono Received Received
  P-65 Expression of TIMP-1 level as a diagnostic and prognostic factor in colon cancer patients: A systematic review Jeannette Tandiono Received Received
  P-66 Experience in our center of bone events not related to the disease in patients with locally advanced or metastatic adenocarcinoma of the pancreas INMACULADA GALLEGO JIMENEZ Received Received
  P-67 Prognostic implication of HER2 overexpression in surgically treated patients with gastric cancer Erkhembayar Enkhbat Received Received
  P-68 Response to neoadjuvant chemotherapy in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma with FLOT-regimen in our setting Clara Garcia Grove Received Received
  P-69 Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience. Alessandro Rizzo Received Received
  P-71 KRYSTAL-10: A randomized phase 3 study of adagrasib (MRTX849) in combination with cetuximab vs chemotherapy in patients with previously treated advanced colorectal cancer with KRASG12C mutation Josep Tabernero Received Received
  P-78 Post hoc analysis in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function in the phase 3 REFLECT study of lenvatinib vs sorafenib Jasmine Huynh Received Received
  P-79 HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody Ken Ito Received Received
  P-81 HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment Ken Ito Received Received
  P-83 The efficacy of chemotherapy for gastric cancer with early recurrence during or after adjuvant S-1 Koshi Kumagai Received Received
  P-85 Relationship between microsatellite instability and neoadjuvant chemotherapy response in gastric or gastroesophageal junction cancer: A meta-analysis Selin Akturk Esen Received Received
  P-91 Safety and efficacy of perioperative FLOT in elderly patients: Real-world data Mafalda Baleiras Received Received
  P-94 Unicentric real-world data from esophageal cancer neoadjuvant treatment according to the CROSS trial protocol Joana Mendona Received Received
  P-95 EV-202: An open-label, multicenter, phase 2 study of enfortumab vedotin in patients with previously treated locally advanced or metastatic solid tumors, including upper gastrointestinal cancers Kei Muro Received Received
  P-96 Analysis of three biographical times of disease in the IMbrave 150 study: A new measure to assess clinical effect Eduardo Ceballos Barbancho Received Received
  P-97 Updated results of HGCSG1603: a phase 2 trial of ramucirumab plus irinotecan combination therapy as second-line treatment for patients with advanced gastric cancer Michio Nakamura Received Received
  P-98 A single-arm study of apatinib plus neoadjuvant chemotherapy followed by resection in patients with locally advanced colorectal adenocarcinoma Aimin Zhang Received Received
  P-99 Circulating RNA detection, circulating tumor cells count (CTC) and molecular tumor profiling in a cohort of untreated metastatic colorectal cancer: A prospective multicenter ancillary study to the randomized VISNÚ trials Susana Rodríguez Received Received
  P-104 Risk of nausea and vomiting in a real-world data cohort of chemotherapy-treated patients with metastatic gastric or gastroesophageal junction adenocarcinoma by medical history of gastrectomy Stefan de Vogel Received Received
  P-112 Compliance analysis of biological samples and questionnaire collection in a colorectal cancer microbiome study: the VHIO experience stefania napoli Received Received
  P-114 Claudin 18 isoform expression in gastric adenocarcinoma and pancreatic adenocarcinoma Takeshi Saito Received Received
  P-117 Survival Outcomes following Systemic Chemotherapy in Stage IVA/B High-grade Mucinous Appendiceal Cancer after Unsuccessful Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Ekaterina Baron Received Received
  P-118 Survival Outcomes of Adjuvant Chemotherapy in Stage IVA/B High-grade Appendiceal Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Ekaterina Baron Received Received
  P-121 Efficacy and toxicity of biosimilar and original bevacizumab in the second-line treatment of metastatic colon cancer in routine clinical practice: Results of an observational multicenter study Mikhail Fedyannin Received Received
  P-122 Gastrointestinal side effects of morphine in cancer pain: A comparison between the smoking and non-smoking patients Fatima Zahra Hijri Received Received
  P-124 Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma Yung-Yeh Su Received Received
  P-125 Caring for more than survival: A survey of patient preferences in advanced hepatocellular carcinoma Siu Hing Lo Received Received
  P-127 Lymphocyte to monocyte ratio as a prognostic factor in stage IV pancreatic ductal adenocarcinoma naive patients before gemcitabine-nab-paclitaxel chemotherapy Andrea Pretta Received Received
  P-128 Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus Andrea Pretta Received Received
  P-129 Concomitant RAS and BRAF mutations: impact on overall survival and progression free survival in metastatic colorectal cancer patients Andrea Pretta Received Received
  P-130 Real-world outcomes of patients with colorectal liver metastases treated with transarterial radioembolization: Results from CIRT, a large European, prospective multi-centre, observational study Niklaus Schaefer Received Received
  P-133 The watch-and-wait approach in stage IV rectal cancer patients: A good alternative for TME surgery? Petra Custers Received Received
  P-135 Pembrolizumab/quavonlimab coformulation in combination with lenvatinib in advanced hepatocellular carcinoma: Phase 2 trial in progress Daneng Li Received Received
  P-136 Detecting panitumumab/FOLFOX responders in K-Ras wild-type metastatic colorectal cancer through an artificial intelligence-based analytical tool Carlos Galmarini Received Received
  P-142 Safety and efficacy of apatinib for non-surgical advanced esophageal cancer: A real-world study Hongfei Zhang Received Received
  P-159 HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction Rita Laeufle Received Received
  P-166 Operative versus nonoperative treatment for stage 0 rectal cancer following chemoradiation therapy Fatima Aurora Aires Received Received
  P-167 Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients Binyi Xiao Received Received
  P-169 Tumor-infiltrating lymphocytes in colorectal cancer: A clinical outcome predictor Marina Vitorino Received Received
  P-174 MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2 gastric or gastroesophageal junction adenocarcinoma: Trial in progress Natalie Pizzimenti Received Received
  P-175 Effectiveness, prognostic factors and safety concerning ablative techniques in liver metastases from gastrointestinal tumors Martín Igor Gómez-Randulfe Rodríguez Received Received
  P-176 A multicenter, randomized phase 1b/2 study of gemcitabine and cisplatin with or without CPI-613 as first-line therapy for patients with advanced unresectable biliary tract cancer (BilT-04) Vaibhav Sahai Received Received
  P-184 Underlining mechanism for the efficacy of tumor treating fields (TTFields) concomitant with sorafenib for treatment of hepatocellular carcinoma Adi Haber Received Received
  P-185 A prospective, randomized, controlled, multicenter phase III clinical trial of apatinib combined with neoadjuvant chemoradiotherapy for patients with locally advanced, HER2-negative, Siewerts type II-III adenocarcinoma of esophagogastric junction Qun Zhao Received Received
  P-186 Vimentin-positive circulating tumor cells as diagnostic and prognostic biomarkers in biliary tract cancer patients Sung Yong Han Received Received
  P-187 Watch-and-wait strategy for DNA mismatch repair-deficient/microsatellite instability-high rectal cancer with a clinical complete response after neoadjuvant immunotherapy: An observational cohort study Qiao-xuan Wang Received Received
  P-188 Propensity score analysis of outcomes following laparoscopic or open radical resection for gallbladder carcinoma in T2 and T3 stages changwei dou Received Received
  P-190 Exploring possible predictors of survival in hepatocellular carcinoma Ins Eiriz Received Received
  P-193 Final results of hepatectomy followed by adjuvant chemotherapy with 3-month capecitabine plus oxaliplatin for colorectal cancer liver metastases: A multicenter phase 2 study Hiroki Hashida Received Received
  P-207 FLOT in clinical practice: Retrospective analysis of an oncological center Raquel Fontes Received Received
  P-208 Pancreatic neuroendocrine neoplasia: Experience of a comprehensive cancer center Sara Coelho Received Received
  P-209 Cancers of the bile duct: A study of 30 cases benamar wassila Received Received
  P-217 The knowledge and awareness for colorectal cancer in advanced colorectal cancer patients in China: A national multicenter study HUIFANG XU Received Received
  P-226 Trifluridin/tipiracil and regorafenib sequencing in Slovenian patients with metastatic colorectal cancer Tanja Mesti Received Received
  P-230 Is stereotactic microwave ablation of resectable colorectal liver metastasis an alternative for liver resection in the Covid-19 pandemic? Thiery Chapelle Received Received
  P-231 Systemic inflammatory biomarkers and their association with survival in gastroesophageal cancer patients: A retrospective single-center analysis Hannah Christina Puhr Received Received
  P-233 Patient information and management by eHealth intervention during colon cancer Melina Campagnaro Received Received
  P-234 Participation of screening and barriers in Chinese patients with advanced colorectal cancer before diagnosis: A national multi-center cross-sectional study Yin Liu Received Received
  P-235 E-health monitoring during pancreatic cancer treatment Melina Campagnaro Received Received
  P-237 Clinical doctors attitudes towards colorectal cancer genetic testing: A national multi-center cross-sectional study Yin Liu Received Received
  P-238 Clinicopathological profile and prognostic factors impacting survival of periampullary carcinoma: A tertiary care centre experience ADITYA KUMAR SINGLA Received Received
  P-240 The diagnosis and treatment of advanced colorectal cancer in China: A national multi-center cross-sectional study HUIFANG XU Received Received
  P-253 Detection of potential molecules that might be implicated in colorectal metastasis to lung Panagiotis Apostolou Received Received
  P-269 Advanced gastric cancer bleeding: Association of hemostatic radiotherapy and iron supplementation - Is there a survival benefit? André Laranja Received Received
  P-279 Thromboembolic complications in colorectal cancers nassima mkedder Received Received
  P-285 Treatment outcomes with sorafenib in advanced hepatocellular carcinoma: A single-center retrospective study Juraj Prejac Received Received
  P-287 Preclinical evaluation of alpelisib (PI3K inhibitor ) and its synergistic effect in combination with ribociclib (CDK 4/6 inhibitor) in colorectal cancer razia aslam Received Received
  P-288 Individual drug-screening and heterogeneity analyses of patient-derived tumoroids: A roadmap to improving therapy in pancreatic cancer Christine Nitschke Received Received
  P-294 Impact of surgical margin status on the survival outcome after surgical resection of gastric cancer: A systematic review and meta-analysis Zhiyuan Jiang Received Received
  P-297 Upfront dihydropyrimidine dehydrogenase deficiency detection to secure 5-FU or capecitabine administration: Application to colorectal cancer patients nassima mkedder Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
12:35
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

ESMO World Congress on Gastrointestinal Cancer

 

30 June -3 July 2021 Virtual Conference
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 30/04/2021 TO 30/06/2022
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert